The inflammasome is a multiprotein signaling complex that mediates inflammatory innate immune responses through caspase 1 activation and subsequent IL-1b secretion. However, because its aberrant activation often leads to inflammatory diseases, targeting the inflammasome holds promise for the treatment of inflammation-related diseases. In this study, it was found that a hot-water extract of Sanguisorba officinalis (HSO) suppresses inflammasome activation triggered by adenosine 5 0 -triphosphate, nigericin, microbial pathogens, and double stranded DNA in bone marrow-derived macrophages. HSO was found to significantly suppress IL-1b production in a dose-dependent manner; this effect correlated well with small amounts of caspase 1 and little ASC pyroptosome formation in HSO-treated cells. The anti-inflammatory activity of HSO was further confirmed in a mouse model of endotoxin-induced septic shock. Oral administration of HSO reduced IL-1b titers in the serum and peritoneal cavity, increasing the survival rate. Taken together, our results suggest that HSO is an inhibits inflammasome activation through nucleotide-binding domain and leucine-rich repeat pyrin domain 3, nucleotide-binding domain and leucine-rich repeat caspase recruitment domain 4 and absent in melanoma 2 pathways, and may be useful for treatment of inflammasomemediated diseases.
well as anti-cancer activity mediated by downregulation of myeloid cell leukemia-1 and Sp1 (5) . In addition, a water-soluble polysaccharide derived from the root of S. officinalis was found to have anti-tumor activity, possibly through immunopotentiation, in a Sarcoma 180-bearing mouse model (7) . These findings indicate that S. officinalis is rich in bioactive compounds with a wide range of activities. However, the anti-sepsis activities of HSO have not been studied. Additionally, there is only limited information about the molecular mechanisms behind the activity of S. officinalis extracts.
Macrophages play an essential role in innate immunity by producing IL-1, IL-6 and TNF-a. IL-1, a major pro-inflammatory cytokine, mediates a variety of innate immune responses against microbial infection. IL-1b and IL-18, which belong to the IL-1 family, are known pathogenic factors in inflammation-mediated diseases and autoimmune diseases. Recent studies have shown that production and secretion of these cytokines are strictly controlled by a complicated multistep process: the inflammasome pathway. Inflammasomes are cytosolic multiprotein complexes comprising NLRs or AIM2, ASC and caspase-1. They are assembled when endogenous and pathogen-associated danger signals are detected (12) . Most cytokines are generated in their active forms and simultaneously secreted. In contrast, IL-1b and IL-18 are synthesized as inactive precursors (pro-IL-1b and pro-IL-18) that accumulate in the cytoplasm of macrophages primed with pathogenassociated molecular patterns such as LPS; this is known as the first signal. The second signal is provided by danger-associated molecular patterns. Upon the second signal, inflammasome complexes are formed, activating caspase-1. This is followed by proteolytic cleavage of pro-IL-1b into active IL-1b, which is then secreted. The most well-known inflammasomes are NLRP and NLRC4 (13) , both of which are activated by ATP, nigericin, or bacteria such as Listeria monocytogenes and Salmonella typhimurium (14) (15) (16) (17) (18) (19) . Recently, a DNA-sensing inflammasome, a member of the interferon-inducible HIN-200 family AIM2, was found to drive ASCdependent caspase-1 activation after cytosolic DNA stimulation (20) (21) (22) . Inflammasomes play a key role in innate immune responses and are essential for initiating adaptive immune responses against a wide array of pathogens (23) (24) (25) . Dysregulated production of IL-1b through inflammasome activation is associated with a number of inflammatory and metabolic disorders (26) . Therefore, inflammasomes could be promising therapeutic targets for controlling various diseases.
In the present study, we investigated the inhibitory effects of HSO on inflammasome activation in LPSprimed BMDMs treated with inflammasome activators and in a mouse model of endotoxin-induced septic shock.
MATERIALS AND METHODS

Plant material
Roots of S. officinalis were purchased from a Korean herbal medicine market in Pyeongtaek (South Korea) and identified by Professor Jong-Sik Jin of Chounbuk National University (Iksan, South Korea). A voucher specimen was deposited with the Department of Oriental Medicine Resources, Chonbuk National University (JBNU-1706001).
Chemicals
Lipopolysaccharide (Escherichia coli 0111:B4), ATP, nigericin, MTT and disuccinimidyl suberate were purchased from Sigma-Aldrich (St. Louis, MO, USA). Anti-cryopyrin (NLRP3), anti-caspase-1 p10, and anti-ASC antibodies were purchased from Santa Cruz Biotechnology, (Dallas, TX, USA). Anti-IL-1b (R&D Systems, Minneapolis, MN, USA) and anti-b-actin antibodies (Cell Signaling Technology, Danvers, MA, USA) were also purchased. The secondary anti-rabbit, anti-mouse and anti-goat IgG antibodies were acquired from Thermo Scientific (Rockford, IL, USA). Unless otherwise stated, all other reagents were purchased from Sigma-Aldrich.
HSO preparation and solvent partitioning
Roots of S. officinalis were dried at room temperature and then powdered, before being extracted twice with 10 volumes of distilled water in a shaking incubator for 24 hr at 60°C. The extract was passed through a filter paper and then evaporated. The dry extract powder was dissolved in sterilized water and then filtered through a 0.2 mm syringe filter (Corning, Wiesbaden, Germany) for further use. The dissolved HSO solution was partitioned with chloroform, ethyl acetate and nBuOH, after which the fractions were lyophilized in a vacuum rotary evaporator.
Animals
C57BL/6 and BALB/C mice (18-22 g at 8-10 weeks of age) were purchased from Samtako Bio Korea (Osan-si, Kyungki-do, Korea) and maintained under conventional conditions (temperature: 22°C-25°C, relative humidity: 50%-70%). All experiments were conducted in accordance with the guidelines of the Animal Care and Use Committee protocol and approved by the Animal Care and Use Committee of Chonbuk National University (CBU 2014-00018).
Preparation of BMDM
Mice were killed by CO 2 inhalation and the medullar cavities of their bones flushed using a 27-gauge needle. The bone marrow cells were plated in a 10 cm culture dish in 10 mL of DMEM with 10% inactivated FBS, 100 g/mL streptomycin and 100 U/mL penicillin, (Hyclone penicillin-streptomycin solution; GE Healthcare, Logan, UT, USA), and 20% L929 supernatant containing macrophage colony-stimulating factor for 7 days. Differentiated BMDMs were harvested and used.
MTT assay
Cell viability was measured by a MTT assay, which is based on assessing mitochondrial activity (27) . In brief, BMDMs were treated with the indicated concentration of HSO for 24 hr and the culture medium discarded, followed by adding MTT solution (0.5 mg/mL) to each well. After 3 hr, the medium was removed and the resultant formazan blue suspended in dimethyl sulfoxide (Daejung Chemicals & Metals, Gyunggido, Korea). Absorbance was determined at 570 nm by using a microplate reader (BioTek, Winooski, VT, USA).
Preparation of bacteria, inflammasome induction and cytokine quantification
Strains of L. monocytogenes and S. typhimurium were kindly provided by Dr. Wan-Kyu Lee of Chungbuk National University. The bacteria were inoculated in BHI (BD Biosciences, Sparks, MD, USA) or LB broth (BD Biosciences) at 37°C for 8 hr. In each experiment, the number of bacteria was determined using a serial dilution plating method. BMDMs were incubated with 500 ng/mL LPS for 6 hr and then stimulated by inducers of NLRP3 inflammasome (5 mM ATP for 1 hr, 5 mM nigericin for 1 hr or L. monocytogenes for 2 hr), NLRC4 inflammasome (S. typhimurium for 2 hr) or AIM2 inflammasome (2 mg/mL dsDNA mixture with Lipofectamine 2000 [Invitrogen, CA, USA, USA]) for 6 hr. To determine the effects of HSO on inflammasome activation, BMDMs were incubated in the absence or presence of different concentrations of HSO for 15 min immediately before initiating inflammasome induction. Production of IL-1b and IL-18 in BMDMs was determined using an ELISA kit (eBioscience). Absorbance was determined at 450 nm using a microplate reader. The amount of cytokines in each sample was calculated by comparison with a standard curve.
Identification of ASC pyroptosome formation in BMDM
This assay was based on a method reported previously (28) . Briefly, cultured BMDMs were incubated with 5 mM ATP for 1 hr and then mixed with 0.5 mL of ice-cold buffer containing 150 mM KCl, 1% Nonidet P-40, 20 mM HEPES-KOH (pH 7.5), 0.1 mM phenylmethylsulfonyl fluoride and a protease inhibitor mixture. The solution was then lysed by passing it through a 21-gauge needle 10 times. The cell lysates were centrifuged at 5000 g and 4°C for 10 min, washed with PBS twice, and then resuspended in 500 mL of PBS. The resuspended cells were cross-linked with 2 mM disuccinimidyl suberate for 30 min and then centrifuged at 5000 g for 10 min. The cross-linked pellets were resuspended in 30 mL SDS sample buffer and analyzed by immunoblotting with a mouse monoclonal anti-ASC antibody.
Protein precipitation and western blot
The medium supernatant was precipitated by adding a quarter volume of TCA solution. This precipitant was incubated for 10 min at 4°C and then centrifuged for 5 min at 20,000 g. The supernatant was discarded and 200 mL of cold acetone added to the pellet and spun for 5 min at 20,000 g. This step was repeated twice. After drying the pellet, 1 Â sample buffer containing 1 M Tris buffer (pH 8.0) was added and the mixture boiled for 10 min. The samples were separated by 15% SDS-PAGE and transferred to nitrocellulose membrane. To determine protein in cell lysates, the cells were lysed with M-PER Mammalian Protein Extraction Reagent (Thermo Scientific) at 4°C and the cell debris removed. The concentrations of protein in lysates were measured by the Bradford assay. The samples were separated by electrophoresis in SDS-polyacrylamide gels and transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA, USA). The membranes were blocked with 5% skim milk for 1 hr at room temperature, incubated with each primary antibody and HRP-conjugated goat antimouse or anti-rabbit IgG antibodies in 5% skim milk, reacted with SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific) and finally visualized using an ImageQuant LAS-4000 system (GE Healthcare, Hatfield, UK).
Identification of ethyl acetate fraction by UPLC-Q-TOF-MS
Compound identification was performed using Acquity I-Class UPLC (Waters, Manchester, UK) with an Acquity UPLC BEH C18 column (2.1 Â 100 mm, 1.7 mm). The column temperature was 40°C. Mobile phase A was water with 0.1% formic acid and mobile phase B acetonitrile with 0.1% formic acid. The injection volume was 2 mL and the flow rate was set at 0.4 mL/min. MS was performed on a Synapt G2-Si system (Waters) with the data acquisition mode at MS E . The operating parameters were as follows: source temperature, 120°C; reservation temperature, 300°C; electrospray ionization positive capillary voltage, 3 kV and negative, 2.5 kV; cone voltage, 30 V; collision energy, 6 eV for low-energy and 20-45 eV for high-energy scan; and scan mass range, 100-1500 m/z. LC-MS data acquisition was controlled by MassLynx 4.1 (Waters). The acquired data was processed using UNIFI1.8. (Waters) with a traditional medicine library.
Establishment of a septic shock model BALB/c female mice received HSO orally (5 or 25 mg/ [kgÁday]) for a week and were intraperitoneally injected with LPS (3 mg/kg). They were examined every 8 hr for 6 days. To measure titers of IL-1b in serum and peritoneal lavage, the mice were killed 6 hr after LPS injection. Blood was collected by cardiac puncture and serum samples prepared by centrifugation for 5 min at 4°C and 8000 g after incubation at room temperature for 30 min. Sterilized PBS (1 mL) was injected into the peritoneal cavity using a 21-gauge needle and peritoneal lavage fluid collected in sterile tubes. After centrifugation at 800 g, the concentration of IL-1b in the supernatant was measured using an ELISA kit.
Statistical analysis
Data are expressed as the mean AE SEM of three independent experiments. The data were processed using one-way anova in GraphPad PRISM (GraphPad Software, La Jolla, CA, USA) in a completely randomized design. Duncan's multiple-range test was used to compare the results of individual treatments. Results with P < 0.05, 0.01, or 0.001 were considered statistically significant.
RESULTS
HSO attenuates ATP-induced NLRP3 inflammasome activation
The effect of HSO on the viability of BMDMs was assessed using an MTT assay. It was found that treatment with HSO for 24 hr did not cause any cytotoxicity, even at the highest concentration tested (500 mg/mL; Fig. 1a) . To elucidate the effect of HSO on inflammasome activation, LPS (500 ng/mL)-primed BMDMs were incubated with different concentrations of HSO in the presence of ATP, a well-known NLRP3 inflammasomeinducer. The combination of LPS and ATP is known to induce NLRP3 inflammasomes by activating purinergic P2 Â 7 receptors (14, 15) . As shown in Figure 1b , HSO attenuated ATP-induced IL-1b secretion in a dosedependent manner. Cells dying as a result of NLRP3 inflammasome activation feature a measurable size increase, swelling and lysis (29) . Cell death after exposure to ATP was evaluated by morphological examination. The features of pyroptosis were observed in BMDMs exposed to ATP, but not in HSO-treated cells (Fig. 1c) . To evaluate maturation of IL-1b, the cleaved and active form of IL-1b in the cell culture supernatant was detected by immunoblotting. As expected, HSO treatment significantly reduced the amount of secreted IL-1b in a dose-dependent manner and this effect was strongly correlated with lower titers of active caspase-1 in HSO-treated BMDMs (Fig. 1d ). In addition, HSO inhibited formation of ASC pyroptosomes, as evidenced by the weaker density of the ASC dimer bands in HSOtreated BMDMs (Fig. 1e) .
HSO inhibits nigericin-induced NLRP3 inflammasome activation
Nigericin is a microbial toxin that acts as a potassium ionophore. Maturation and secretion of IL-1b in response to nigericin is mediated by NLRP3 (15) . Here, whether HSO could inhibit the nigericin-induced NLRP3 inflammasome was tested. Prior to treatment with 5 mM nigericin for 1 hr, HSO was added for 15 min. The greatest concentrations of IL-1b were observed in LPSprimed BMDMs treated with nigericin without HSO. In contrast, IL-1b concentrations decreased significantly when the concentration of HSO was increased (Fig. 2a) .
HSO inhibited release of IL-1b and caspase-1 in nigericininduced NLRP3 inflammasomes, this being confirmed by an immunoblot (Fig. 2b) . In addition, the presence of HSO suppressed nigericin-induced formation of ASC pyroptosomes (Fig. 2c) .
Effects of HSO on L. monocytogenesinduced inflammasome activation
It has been suggested that L. monocytogenes that escape from the phagolysosome with listeriolysin O are recognized by NLRP3 and AIM2 in the cytoplasm, thus activating caspase-1 (16, 19) . In this study, whether HSO could modulate the inflammasomes triggered by L. monocytogenes was tested. LPS-primed BMDMs were infected with L. monocytogenes and the mature form of IL-1b was therefore secreted. HSO treatment significantly decreased IL-1b concentrations in a dosedependent manner (Fig. 3a) . Such reductions were consistent with the band patterns of IL-1b and caspase-1 in immunoblots (Fig. 3b) . ASC dimerization completely disappeared when HSO concentration was increased; thus, LM-induced NLRP3/AIM2 inflammasome activation was interrupted in BMDMs cultured in the presence of HSO (Fig. 3c) .
Inhibition of S. typhimurium-induced NLRC4 inflammasome activation by HSO
S. typhimurium is known to induce NLRC4 inflammasomes (17, 18, 30) . Here, it was found that HSO suppressed IL-1b production triggered by the NLRC4 inflammasomes that were activated by S. typhimurium (Fig. 4a, b) . Simultaneously, caspase-1 activation was attenuated by HSO treatment (Fig. 4b) . Dimerization of ASC gradually decreased as the concentration of HSO increased (Fig. 4c) . Inhibitory effect of HSO on dsDNA-induced activation of AIM2 inflammasomes AIM2 can recognize cytosolic dsDNA, inducing caspase-1 cleavage and formation of inflammasomes with ASC (21) . In the present study, small doses of HSO (10 or 50 mg/mL) reduced IL-1b secretion and no IL-1b production was observed at higher concentrations of HSO during dsDNA-induced AIM2 inflammasome activation (Fig. 5a ). These results are consistent with immunoblots of IL-1b and caspase-1 (Fig. 5b) . In addition, HSO interfered with formation of ASC complexes (Fig. 5c ), indicating that HSO probably blocks recognition of dsDNA by AIM2 and thus inhibits inflammasome activation. 
HSO increases the survival rate of mice during LPS-induced septic shock
The effect of HSO in a mouse model of endotoxininduced septic shock was investigated because some studies have suggested that inflammasome pathways play an essential role in septic shock (31, 32) . The survival rate of mice with LPS-induced septic shock that received HSO orally (5 or 25 mg/[kgÁday]) for a was greatly improved over that of mice who di not receive HSO (Fig. 6a) . Reduced IL-1b secretion was observed in both serum and peritoneal lavage fluid of mice treated with 25 mg/(kgÁday) HSO. Although 5 mg/kg HSO was also effective in terms of the survival rate, the concentrations of IL-1b in the serum or peritoneal lavage of mice treated with 5 mg/kg HSO were not significantly lower. Next, whether HSO had a therapeutic effect on endotoxin-induced septic shock was investigated. Thirty minutes after LPS injection, mice received HSO (25 or 100 mg/kg). Although all mice that received LPS died within 60 hr, the survival rates of mice treated with 25 and 100 mg/kg HSO via oral administration were greater by 40% and 80%, respectively (Fig. 6b ). These observations indicate that HSO can act as a therapeutic agent for endotoxininduced septic shock by downregulating inflammasome pathways.
Characterization of HSO by solvent partitioning and UPLC-Q-TOF-MS, and its inhibitory effects
Active ingredients of SO extract have been investigated in several studies, and it has been found that chloroform and n-BuOH, and tested for cytotoxicity towards BMDMs. None of the solvent fractions affected the viability of BMDMs (data not shown). When LPS (500 ng/mL)-primed BMDMs were incubated with these fractions in the presence of ATP, the ethyl acetate fraction reduced IL-1b secretion, whereas the chloroform and n-BuOH fractions did not (Fig. 7a) . The ethyl acetate fraction was therefore analyzed using UPLC-Q-TOF-MS, and peaks were identified by comparing the MS/MS spectra to reported data. As shown in Figure 7b and c, ten compound peaks were identified, including euphormisin M3, ellagic acid, 3,8-dihydroxy-4,10-dimethoxy-7-oxo- [2] benzopyrono [4,3- 
0 -di-O-methylellagic acid, arjunglucoside II, irilone, chikusetsusaponin II, pomolic acid-3-b-O-a-L-arabionopyranoside, belachinal, and deglucose chikusetsusaponin IVa, indicating that these compounds are probably present in HSO. These findings suggested that compounds present in the ethyl acetate fraction may be responsible for the inhibitory effect of HSO on inflammasome pathways and protective role of HSO in endotoxininduced septic shock.
DISCUSSION
Extracts of S. officinalis have been shown to exert various physiological effects, including immunomodulation; however, the underlying molecular mechanisms are not well understood, especially in acute endotoxin-induced shock. This is the first study to reveal that HSO can act as a potent inflammasome inhibitor and protect mice from LPS-induced lethal septic shock.
Numerous studies have searched for novel therapeutic agents against inflammatory diseases in natural plant-based products. Because inflammasomes are considered key players in inflammation, studies have recently focused on detecting plant extracts that can inhibit inflammasome activation. For instance, studies have shown that extracts from Aloe vera and Syneilesis palmata (Thunb.) Maxim. significantly reduce IL-1b production by inhibiting NLRP3 inflammasomes (36) (37) (38) . Another study had shown that Korean red ginseng extracts suppress NLRP3 and AIM2 inflammasome activation, protecting mice from lethal endotoxin shock (39) . A study on bamboo vinegar had shown that it suppresses NLRP3 inflammasome activation through mechanisms involving attenuation of reactive oxygen species production and protein kinase C-a/d activation (40) . Here, we demonstrated that IL-1b secretion triggered by NLRP3 inflammasomes via ATP or nigericin stimulation in LPS-primed BMDMs, is significantly attenuated by HSO. We observed a similar tendency in BMDMs infected with Listeria monocytogenes, which is known to activate NLRC4 inflammasomes. In addition, HSO blocked AIM2 inflammasomes activated by S. typhimurium and intracellular dsDNA. This inhibitory activity of HSO is likely mediated by reduced ASC pyroptosome formation and caspase-1 cleavage. Inflammasome pathways are known to be involved in endotoxin-induced septic shock (41) . Here, we confirmed the inhibitory effects of HSO on inflammasome activation through in vivo experiments. In this study, oral administration of HSO enhanced survival rates in a mouse model of endotoxin-induced septic shock. In addition, amounts of IL-1b in serum or peritoneal lavage fluid were found to be significantly lower in mice treated with HSO. A study has shown that mice lacking NLRP3 and caspase-1 are resistant to LPS-induced septic shock (15) . Nevertheless, caspase-1 is necessary for LPS-induced endotoxemia, whereas caspase-1 substrates, both IL-1b and IL-18, are dispensable (42) . The same group had also demonstrated that HMGB1 secretion occurs downstream of caspase-1 activation and is crucial for endotoxemia. Given that HMGB1 is released upon cell death by pyroptosis and causes inflammation (43) , it is plausible that reduction of pyroptosis by HSO is also involved in protection from endotoxin shock.
S. officinalis is a traditional herbal medicine; thus, it is useful to investigate the biologically active components in it. Several compounds, including ziyuglycoside, 7-Ogalloyl-(þ)-catechin, 3-O-galloylprocyanidin B-3 and pomolic acid, have been identified in S. officinalis (3, 44, 45) . In the present study, we analyzed a hot-water extract of S. officinalis and identified a number of active compounds, including euphormisin M3, ellagic acid, 3,8-dihydroxy-4,10-dimethoxy-7-oxo- [2] benzopyrono [4,3-b] [1]benzopyran-7-(5H)-one, 3,3'-di-O-methylellagic acid, arjunglucoside II, irilone, chikusetsusaponin II, pomolic acid-3-b-O-a-L-arabinopyranoside, belachinal and deglucose chikusetsusaponin IVa. Several of these compounds, including ellagic acid, pomolic acid and ziyuglycoside, have been studied previously.
Ellagic acid has been shown to have anti-inflammatory, anti-proliferative, apoptotic and antioxidant activities (46) (47) (48) (49) ; pomolic acid has been shown to exhibit antiinflammatory and anti-apoptotic activities (50); and ziyuglycoside has been shown to suppress inflammation and proliferation, as well as induce cell cycle arrest and apoptosis (51, 52) . Therefore, the predominant components in HSO may be valuable sources of antiinflammatory agents. Further research is therefore needed to characterize the active compounds.
Taken together, our results show that HSO inhibits IL-1b secretion by suppressing inflammasome pathways triggered by ATP, nigericin, LM, S. typhimurium or dsDNA. Thus, HSO inhibits inflammasome activation of NLRP3, NLRC4 and AIM2 pathways. It is also clear that HSO significantly reduces caspase-1 activation, and that this reduction is associated with less IL-1b secretion and pyroptosome formation. In addition, oral administration of HSO enhanced survival rates in a mouse model of endotoxin-induced septic shock. These results may provide useful insights into novel molecular mechanisms by which HSO exerts its potent anti-inflammatory effects.
